ANTIBODY-RESPONSE TO HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 PROTEASE ACCORDING TO RISK GROUP AND DISEASE STAGE

被引：20
|
作者：
BOUCHER, CAB
DEJAGER, MH
DEBOUCK, C
EPSTEIN, LG
DEWOLF, F
WOLFS, TFW
GOUDSMIT, J
机构：
[1] MUNICIPAL HLTH SERV,DEPT INFECT DIS,AMSTERDAM,NETHERLANDS
[2] SK&F LABS,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19479
[3] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK,NJ 07103
[4] CHILDRENS HOSP,AIDS PROGRAM,NEWARK,NJ 07103
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 1989年 / 27卷 / 07期
关键词：
D O I：
10.1128/JCM.27.7.1577-1581.1989
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1577 / 1581
页数：5
相关论文
共 50 条
  • [31] Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach
    Dayer, Mohammad Reza
    Dayer, Mohammad Saaid
    MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2014, 3 (04) : 253 - 267
  • [32] DESIGN OF TIGHT-BINDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS
    VACCA, JP
    RETROVIRAL PROTEASES, 1994, 241 : 311 - 334
  • [33] MUTAGENESIS OF PROTEASE CLEAVAGE SITES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN
    TRITCH, RJ
    CHENG, YSE
    YIN, FH
    ERICKSONVIITANEN, S
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 922 - 930
  • [34] Risk factors for human immunodeficiency virus type-1 acquisition in women in Africa
    Benki, S
    McClelland, RS
    Overbaugh, J
    JOURNAL OF NEUROVIROLOGY, 2005, 11 : 58 - 65
  • [35] Human immunodeficiency virus type 1 protease inhibitors
    McDonald, CK
    Kuritzkes, DR
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (09) : 951 - 959
  • [36] POTENTIAL ROLE OF THE VIRAL PROTEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED PATHOGENESIS
    SHOEMAN, RL
    HONER, B
    MOTHES, E
    TRAUB, P
    MEDICAL HYPOTHESES, 1992, 37 (03) : 137 - 150
  • [37] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - RELATIONSHIP OF RISK GROUP AND AGE TO RATE OF PROGRESSION TO AIDS
    OPERSKALSKI, EA
    STRAM, DO
    LEE, H
    ZHOU, Y
    DONEGAN, E
    BUSCH, MP
    STEVENS, CE
    SCHIFF, ER
    DIETRICH, SL
    MOSLEY, JW
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) : 648 - 655
  • [38] DOES PELVIC INFLAMMATORY DISEASE INCREASE THE RISK FOR ACQUISITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    IRWIN, K
    ELLERBROCK, T
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) : 898 - 899
  • [39] CHARACTERIZATION OF AN ACTIVE SINGLE POLYPEPTIDE FORM OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    DIIANNI, CL
    DAVIS, LJ
    HOLLOWAY, MK
    HERBER, WK
    DARKE, PL
    KOHL, NE
    DIXON, RAF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (28) : 17348 - 17354
  • [40] Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance
    Swanstrom, R
    Erona, J
    PHARMACOLOGY & THERAPEUTICS, 2000, 86 (02) : 145 - 170
12345